pre-IND – is an acronym for pre-investigational new drug. As new therapies are being developed, they reach a stage where testing is ready to begin. In the US, the FDA requires that an IND application be filed before testing begins.
Due to data protection policies, USA residents can not access our data.
Your content has been curated